Clara Gram Gjesdal

Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial

Kristin Kaasen Jørgensen, Inge Christoffer Olsen, Guro Løvik Goll et al. · The Lancet · 2017 · 806 citations

Pharmacy, Internal Medicine, Pharmacotherapy +11

Homocysteine, cysteine, and body composition in the Hordaland Homocysteine Study: does cysteine link amino acid and lipid metabolism?

Amany Elshorbagy, Eha Nurk, Clara Gram Gjesdal et al. · American Journal of Clinical Nutrition · 2008 · 186 citations

Life Sciences, Biochemistry, Physiology +17

Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone

Kristian Løvås, Clara Gram Gjesdal, Monika H. E. Christensen et al. · European Journal of Endocrinology · 2009 · 165 citations

Medicine, Endocrinology, Bone Metabolism +16

Plasma Total Homocysteine Level and Bone Mineral Density

Clara Gram Gjesdal · Archives of Internal Medicine · 2006 · 155 citations · Full text

Medicine, Biostatistics, Bone Metabolism +15

Mortality following the first hip fracture in Norwegian women and men (1999–2008). A NOREPOS study

Tone Kristin Omsland, Nina Emaus, Grethe S. Tell et al. · Bone · 2014 · 152 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +3